A profile about the people, projects and experiences behind their work. Discover their career, contributions and connections.
CareerDetails being loaded
Cosigned byDetails being loaded
CosignedDetails being loaded
CNCompany name
2022
Founder
CNCompany name
2022
Founder
KKallyopeDeveloping innovative medicines for migraine and metabolic disorders.
About
At Kallyope, we are leveraging unique insights into neural signaling pathways and developing innovative medicines for the treatment of migraine. Our late-stage pipeline focuses on delivering an effective, easy to use, first-in-class medication.
Kallyope was founded by world-leading neuroscientists whose groundbreaking research into previously unexplored neural networks is now being carried forward by a team of experienced drug developers.
Elismetrep, our lead asset being developed for the acute treatment of migraine, is in Phase 3.
Details
Founded2015
HeadquartersNew York City, New York, United States